In the phase 3 ACHIEVE-3 trial , adults with type 2 diabetes inadequately controlled by metformin were randomized to receive orforglipron or oral semaglutide (7 mg and 14 mg, doses approved for type 2 diabetes)
Understanding what to expect after stopping, and how to best support your body, is key to maintaining long-term results
Although extensive research has been conducted on plant stress responses, the interplay between MYB TFs and phytohormones in mediating abiotic stress tolerance remains underexplored
Since many aetiologies of non-diabetic nephropathy are characterized by intraglomerular hypertension (37), we hypothesize that SGLT2i acutely decreases GFR and proteinuria in patients without diabetes at risk of progressive kidney function loss via a glucose-independent hemodynamic mechanism
Your treatment plan is built around your labs, your symptoms, your history, and your goals
Unlike traditional syringes, these pens offer a more discreet and streamlined approach to self-administering medication